SHE:300255 Revenue

Hebei Changshan Biochemical Pharmaceutical had revenue of 216.25M CNY in the quarter ending September 30, 2024, a decrease of -32.26%. This brings the company's revenue in the last twelve months to 1.05B, down -37.29% year-over-year. In the year 2023, Hebei Changshan Biochemical Pharmaceutical had annual revenue of 1.41B, down -39.63%.

Revenue (ttm)

1.05B

Revenue Growth

-37.29%

P/S Ratio

14.64

Revenue / Employee

748.12K

Employees

1,410

Market Cap

18.39B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.41B	-925.79M	-39.63%
Jan 1, 2023	2.34B	-631.82M	-21.29%
Jan 1, 2022	2.97B	604.26M	25.56%
Dec 31, 2020	2.36B	292.31M	14.11%
Dec 31, 2019	2.07B	418.85M	25.34%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shenzhen Mindray Bio-Medical Electronics	37.11B
Jiangsu Hengrui Medicine	26.00B
WuXi AppTec	38.50B
Aier Eye Hospital Group	20.62B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Shanghai United Imaging Healthcare	10.93B
Yunnan Baiyao Group Co.,Ltd	39.34B
Sichuan Biokin Pharmaceutical	5.85B

Revenue Rankings